Titan Pharmaceuticals (NASDAQ:TTNP) Now Covered by StockNews.com
Analysts at StockNews.com initiated coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Get Free Report) in a report released on Wednesday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Trading Up 11.6 % NASDAQ:TTNP opened at $3.94 on Wednesday. The stock has a market capitalization of $3.60 million, a […]
